Alcami Corporation, a contract development and manufacturing organisation (CDMO), announced on Thursday that it has named Jamie Iudica as its new chief manufacturing officer.
Iudica has over 25 years of experience in the pharmaceutical industry, including leadership roles in engineering, manufacturing, and supply chain operations. He has served as chief manufacturing officer at Istari Oncology and in multiple manufacturing and operations leadership roles throughout his career including executive roles at Xellia Pharmaceuticals, Pfizer, and Hospira.
Patrick Walsh, chairman and chief executive officer at Alcami Corporation, said, 'Jamie's extensive expertise in drug product manufacturing operations will be integral as we expand the Alcami manufacturing and operations footprint.'
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar